Subsequently, TNF-α also inhibits the ubiquitination and degradation of PD-L1 protein through COP9 signalosome subunit 5 (CSN5), thereby enhancing the stability of PD-L1 and sensitizing cancer cells to immunotherapy [297]. The gene discussed is COPS5; the disease is cancer.